KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Profit After Tax (2018 - 2025)

Adaptive Biotechnologies' Profit After Tax history spans 8 years, with the latest figure at -$13.6 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 59.6% year-over-year to -$13.6 million; the TTM value through Dec 2025 reached -$59.5 million, up 62.71%, while the annual FY2025 figure was -$59.5 million, 62.72% up from the prior year.
  • Profit After Tax for Q4 2025 was -$13.6 million at Adaptive Biotechnologies, down from $9.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $9.5 million in Q3 2025 and bottomed at -$69.4 million in Q4 2023.
  • The 5-year median for Profit After Tax is -$46.9 million (2024), against an average of -$42.9 million.
  • The largest annual shift saw Profit After Tax crashed 72.98% in 2023 before it soared 129.77% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$61.5 million in 2021, then surged by 34.7% to -$40.1 million in 2022, then tumbled by 72.98% to -$69.4 million in 2023, then soared by 51.57% to -$33.6 million in 2024, then soared by 59.6% to -$13.6 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Profit After Tax are -$13.6 million (Q4 2025), $9.5 million (Q3 2025), and -$25.6 million (Q2 2025).